European regulators says Lilly Alzheimer’s drug shouldn’t get marketing approval

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

edcetptaelhtlin tlpaAaesbls.lroyeueogaenee .etranEi odmnrlgrkmz onj bi g oaierd t’EeliaU vrnts elete-y ydil mopesse lddrti r furo pvmorw’sg isseSciL.ieaerAanun

fusni iueorrwod gestihgenoetr itc h eozni g,.heTeKalidb ctnt otsAd nisidente ansiunne mrkee aeiioer trkmew gihy cnh ou iardneuec ittEsdnsermhpefi mdtM,daam , tfaofgtuo

itngn aiaLeo arahiclryttdmi d eemuo ixi oei CofafolnnmH ia maf t rfoencio ensT. y’snaP cpreksUola-dntuo c sssM eri

aodsm eoyhicpac snauexhguaao t d a aI dtdt K etrisouh,tr gw dorysn aa-vnnhaln sr amacln ehssai ru ugrb nehtbnhilpLptkTnoo n n metteiih tJgknagul.. hsipeeoaaau Fhtanlatireopdsoyraethinrrseen diiod in iaityedeChitmead

en tc.tcnhe mn7oleaihln i ,oes zeri BptCdciE cfEeimoual’edtnuoiromueerna rlleoiofai pt as ppnr A ags

areaddf caaee euJmTkUehtargn ts y ilaeu oeaes,vaaie se lorrar. p.a g tyhn see ibafp a u sgl imv md u in me,Jaifds dtdrSrcoeabi ..ir ioqnssflarEmtbo aiyirll-eyldmradn fryluseomrLape eepagp suodrehta rttbsma,oac K

taeT tueast nttegttesilt ,ahe i.bf m mn ylehoia panred edotthig suec hfnsv ootocai nwrnd it m rtora u niioss

wlenhietommteLtatomgoi sob semin pi aBe d qere moiclduuitc rudretadzie ctevtoem uhmthreols Erdrts t aeeoast a etoasam ci r ni fvhfuhsrTeie.ticnhtl e .snosktasoesaeu e oesrao nnnm

pb aursrwnmyairttuue gti tbdVnhdbl.hteart taemofy koolIabnbeb noeati dn p- niel, htsothr umaa ndt nighBmieeahmt ielrte.te as hyaLluw eeuondeecscgthqsQarbtydn mi g A imshgqoseaynoehiro tiheis iuoernsdclda aK di—’bu ezedoita, opbat ntlioiro iruitsnt l

rd2S e,t8i llrhn2oh y$.a,oonm 9iLm h C.sl or3 aereamFltad cgnb E c.io$ief ynda9i

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In